Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4211367 | 0.84 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1MYCESR1 | |
| SCHEMBL8019701 | 0.83 | CYP2A6 (0.47) | SMN1; SMN2ALDH1A1TDP1KMT2APOLB | |
| SCHEMBL21383062 | 0.81 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1ALOX15TP53 | |
| SCHEMBL13495898 | 0.81 | PARP1 (0.48) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL29421064 | 0.79 | CES2 (0.63) | TSHRSMN1; SMN2ALDH1A1MYCESR1 | |
| SCHEMBL310259 | 0.79 | CES2 (0.63) | TSHRSMN1; SMN2ALDH1A1MYCESR1 | |
| SCHEMBL13495879 | 0.78 | HDAC6 (0.48) | TSHRSMN1; SMN2CA2 | |
| SCHEMBL9132393 | 0.78 | TDP1 (0.53) | TSHRSMN1; SMN2ALDH1A1ALOX15HSD17B10 | |
| SCHEMBL6917591 | 0.77 | CES2 (0.61) | TSHRSMN1; SMN2ALDH1A1MYCESR1 | |
| SCHEMBL6915822 | 0.77 | CES2 (0.61) | TSHRSMN1; SMN2ALDH1A1MYCESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | claimed |
| CN-104379714-A | Malodor reduction compositions | PROCTER & GAMBLE | 2015-02-25 | — | — | CN | claimed |
| US-12245446-B2 | Semiconductor device having quantum dots, display device, imaging system, and moving body | CANON KABUSHIKI KAISHA (JP) | 2025-03-04 | — | — | US | disclosed |
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | disclosed |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| CN-115484948-A | Compound and use thereof | 福宏治疗公司 | 2022-12-16 | — | — | CN | disclosed |
| EP-4096657-A1 | COMPOUNDS AND USES THEREOF | Foghorn Therapeutics Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| CN-113285024-A | Semiconductor device having quantum dots, display device, imaging system, and moving object | 佳能株式会社 | 2021-08-20 | — | — | CN | disclosed |
| US-20210242416-A1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY | CANON KABUSHIKI KAISHA (JP) | 2021-08-05 | — | — | US | disclosed |
| US-20040067990-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | BARRISH JOEL C (US) | 2004-04-08 | — | — | US | disclosed |
| US-20040067989-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | BARRISH JOEL C (US) | 2004-04-08 | — | — | US | disclosed |
| US-6706717-B2 | ANTICANCER AGENTS; IMMUNOLOGY DISEASES; ANTIALLERGENS; ANTIINFLAMMATORY AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2004-03-16 | — | — | US | disclosed |
| EP-1347971-A1 | THIAZOLYL INHIBITORS OF TEC FAMILY TYROSINE KINASES | Bristol-Myers Squibb Company (US) | 2003-10-01 | — | — | EP | disclosed |
| CN-1423635-A | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CHEMICAL IND CO LTD (JP) | 2003-06-11 | — | — | CN | disclosed |
| US-20030069238-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | BRISTOL-MYERS SQUIBB COMPANY | 2003-04-10 | — | — | US | disclosed |
| WO-2002050071-A1 | THIAZOLYL INHIBITORS OF TEC FAMILY TYROSINE KINASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-06-27 | — | — | WO | disclosed |
| EP-0409729-B1 | Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics | CIRD GALDERMA (FR) | 1994-01-12 | — | — | EP | disclosed |
| EP-0409729-A1 | Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | TSHR 4351/4885SMN1; SMN2 40/4885ALDH1A1 2571/4885 |
| US-20040067990-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | TEC, LCK, LTK | TSHR 2760/4885SMN1; SMN2 4593/4885ALDH1A1 2945/4885 |
| US-20040067989-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | TEC, LCK, LTK | TSHR 2760/4885SMN1; SMN2 4593/4885ALDH1A1 2945/4885 |
| US-20030069238-A1 | Thiazolyl inhibitors of Tec family tyrosine kinases | TEC, LCK, LTK | TSHR 2760/4885SMN1; SMN2 4593/4885ALDH1A1 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.